US OptionsDetailed Quotes
REPL250117C22500
- 0.45
- 0.000.00%
15min DelayTrading Nov 22 13:53 ET
0.00High0.00Low
0.00Open0.45Pre Close0 Volume2 Open Interest22.50Strike Price0.00Turnover188.45%IV85.38%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.45Extrinsic Value100Contract SizeAmericanOptions Type0.1696Delta0.0413Gamma27.51Leverage Ratio-0.0309Theta0.0011Rho4.67Eff Leverage0.0082Vega
Replimune Stock Discussion
The market overall advanced Friday. Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded +0.35%, the $Dow Jones Industrial Average (.DJI.US)$ climbed 0.97%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.16%.
MACRO
In macroeconomics, S&P Global released its composite and service PMI. Composite came in at a two-year high, 55.3...
$Super Micro Computer (SMCI.US)$ climbed 15%, after earlier this week, the firm said it submitted a plan to release its six-month delayed 10k with a new auditor, BDO USA, and filed for a time extension to file it...
Replimune Receives Breakthrough Therapy Designation for Rp1 and Submits Rp1 Biologics License Application to the FDA Under the Accelerated Approval Pathway
No comment yet